These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16879102)

  • 1. TAK1-binding protein 1 is a pseudophosphatase.
    Conner SH; Kular G; Peggie M; Shepherd S; Schüttelkopf AW; Cohen P; Van Aalten DM
    Biochem J; 2006 Nov; 399(3):427-34. PubMed ID: 16879102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the interaction of TAK1 kinase with its activating protein TAB1.
    Brown K; Vial SC; Dedi N; Long JM; Dunster NJ; Cheetham GM
    J Mol Biol; 2005 Dec; 354(5):1013-20. PubMed ID: 16289117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evolutionarily conserved motif in the TAB1 C-terminal region is necessary for interaction with and activation of TAK1 MAPKKK.
    Ono K; Ohtomo T; Sato S; Sugamata Y; Suzuki M; Hisamoto N; Ninomiya-Tsuji J; Tsuchiya M; Matsumoto K
    J Biol Chem; 2001 Jun; 276(26):24396-400. PubMed ID: 11323434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization.
    Lu M; Lin SC; Huang Y; Kang YJ; Rich R; Lo YC; Myszka D; Han J; Wu H
    Mol Cell; 2007 Jun; 26(5):689-702. PubMed ID: 17560374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2C alpha.
    Marley AE; Sullivan JE; Carling D; Abbott WM; Smith GJ; Taylor IW; Carey F; Beri RK
    Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):801-6. PubMed ID: 9003365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the p38α MAP kinase in complex with a docking peptide from TAB1.
    Xin F; Wu J
    Sci China Life Sci; 2013 Jul; 56(7):653-60. PubMed ID: 23722236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the protein serine/threonine phosphatase 2C at 2.0 A resolution.
    Das AK; Helps NR; Cohen PT; Barford D
    EMBO J; 1996 Dec; 15(24):6798-809. PubMed ID: 9003755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants for substrate specificity of the bacterial PP2C protein phosphatase tPphA from Thermosynechococcus elongatus.
    Su J; Forchhammer K
    FEBS J; 2013 Jan; 280(2):694-707. PubMed ID: 22212593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta ), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1.
    Ge B; Xiong X; Jing Q; Mosley JL; Filose A; Bian D; Huang S; Han J
    J Biol Chem; 2003 Jan; 278(4):2286-93. PubMed ID: 12429732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex.
    Mendoza H; Campbell DG; Burness K; Hastie J; Ronkina N; Shim JH; Arthur JS; Davis RJ; Gaestel M; Johnson GL; Ghosh S; Cohen P
    Biochem J; 2008 Feb; 409(3):711-22. PubMed ID: 18021073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrpZ, a Salmonella enterica serovar Typhi serine/threonine protein phosphatase 2C with dual substrate specificity.
    Lai SM; Moual HL
    Microbiology (Reading); 2005 Apr; 151(Pt 4):1159-1167. PubMed ID: 15817783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoactivation of transforming growth factor beta-activated kinase 1 is a sequential bimolecular process.
    Scholz R; Sidler CL; Thali RF; Winssinger N; Cheung PC; Neumann D
    J Biol Chem; 2010 Aug; 285(33):25753-66. PubMed ID: 20538596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants that control the specific interactions between TAB1 and p38alpha.
    Zhou H; Zheng M; Chen J; Xie C; Kolatkar AR; Zarubin T; Ye Z; Akella R; Lin S; Goldsmith EJ; Han J
    Mol Cell Biol; 2006 May; 26(10):3824-34. PubMed ID: 16648477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Myristoylation is essential for protein phosphatases PPM1A and PPM1B to dephosphorylate their physiological substrates in cells.
    Chida T; Ando M; Matsuki T; Masu Y; Nagaura Y; Takano-Yamamoto T; Tamura S; Kobayashi T
    Biochem J; 2013 Feb; 449(3):741-9. PubMed ID: 23088624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAK1-binding proteins (TAB1 and TAB2) in grass carp (Ctenopharyngodon idella): identification, characterization, and expression analysis after infection with Ichthyophthirius multifiliis.
    Zhao F; Li YW; Pan HJ; Shi CB; Luo XC; Li AX; Wu SQ
    Fish Shellfish Immunol; 2014 Jun; 38(2):389-99. PubMed ID: 24747054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1.
    Sakurai H; Miyoshi H; Mizukami J; Sugita T
    FEBS Lett; 2000 Jun; 474(2-3):141-5. PubMed ID: 10838074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of a third metal ion by the human phosphatases PP2Cα and Wip1 is required for phosphatase activity.
    Tanoue K; Miller Jenkins LM; Durell SR; Debnath S; Sakai H; Tagad HD; Ishida K; Appella E; Mazur SJ
    Biochemistry; 2013 Aug; 52(34):5830-43. PubMed ID: 23906386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of TAK1 and TAB1 enhances LPS-induced cytokine release via modulating NF-κB activation (Larimichthys crocea).
    Bao SY; Sun QX; Yao CL
    Fish Shellfish Immunol; 2018 Mar; 74():450-458. PubMed ID: 29325713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways.
    Sakurai H; Nishi A; Sato N; Mizukami J; Miyoshi H; Sugita T
    Biochem Biophys Res Commun; 2002 Oct; 297(5):1277-81. PubMed ID: 12372426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of the PP2C phosphatase tPphA from Thermosynechococcus elongatus: a flexible flap subdomain controls access to the catalytic site.
    Schlicker C; Fokina O; Kloft N; Grüne T; Becker S; Sheldrick GM; Forchhammer K
    J Mol Biol; 2008 Feb; 376(2):570-81. PubMed ID: 18164312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.